5/7
07:18 am
smmt
Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $7.00 price target on the stock.
High
Report
Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $7.00 price target on the stock.
5/1
07:12 am
smmt
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024 [Yahoo! Finance]
High
Report
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024 [Yahoo! Finance]
5/1
07:00 am
smmt
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
High
Report
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
4/24
04:30 pm
smmt
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
Low
Report
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
4/11
04:30 pm
smmt
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
Medium
Report
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
4/10
07:05 am
smmt
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum [Yahoo! Finance]
Low
Report
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum [Yahoo! Finance]
4/10
07:00 am
smmt
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
Low
Report
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
4/9
04:39 pm
smmt
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor [Yahoo! Finance]
Low
Report
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor [Yahoo! Finance]
5/1/2024
07:00 am
SMMT
summit therapeutics inc.
IN-LINE
Report
19.6%
summit therapeutics inc.
5/13
08:05 am
smmt
Form 8-K Summit Therapeutics Inc. For: May 13
Medium
Report
Form 8-K Summit Therapeutics Inc. For: May 13
5/13
07:49 am
smmt
Form 424B5 Summit Therapeutics Inc.
Medium
Report
Form 424B5 Summit Therapeutics Inc.
5/1
08:45 am
smmt
Form S-8 Summit Therapeutics Inc.
High
Report
Form S-8 Summit Therapeutics Inc.
5/1
08:19 am
smmt
Form 8-K Summit Therapeutics Inc. For: May 01
High
Report
Form 8-K Summit Therapeutics Inc. For: May 01
5/1
08:12 am
smmt
Form 10-Q Summit Therapeutics Inc. For: Mar 31
High
Report
Form 10-Q Summit Therapeutics Inc. For: Mar 31
4/25
05:04 pm
smmt
Form DEF 14A Summit Therapeutics Inc. For: Jun 14
High
Report
Form DEF 14A Summit Therapeutics Inc. For: Jun 14
4/15
09:22 am
smmt
Form 4 Summit Therapeutics Inc. For: Apr 11 Filed by: Ronaghi Mostafa
Low
Report
Form 4 Summit Therapeutics Inc. For: Apr 11 Filed by: Ronaghi Mostafa
4/15
09:19 am
smmt
Form 3 Summit Therapeutics Inc. For: Apr 11 Filed by: Ronaghi Mostafa
Low
Report
Form 3 Summit Therapeutics Inc. For: Apr 11 Filed by: Ronaghi Mostafa
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register